Claims
- 1. The method of treating a cancer sensitive to treatment with hexadecylphosphocholine, which consists of administering to a patient afflicted with said cancer a therapeutically effective anti-cancer amount of hexadecylphosphocholine.
- 2. Method of claim 1, wherein said cancer is an internal tumor or internal metastasis, a plural carcinosis, a malignant ascites, a pericardial carcinoma, a mammary cancer or a bladder carcinoma.
- 3. Method of claim 1, wherein said hexadecylphosphocholine is administered in an oral formulation.
- 4. Method of claim 3, wherein said hexadecylphosphocholine is administered in an amount ranging from 5 mg to 100 mg of hexadecylphosphocholine per kilogram of body weight of said patient.
- 5. Method of claim 1, wherein said hexadecylphosphocholine is administered in connection with starch, cellulose, lactose, formalin-casein, modified starch, magnesium stearate, calcium hydrogen phosphate, highly dispersed silicic acid, talc, phenoxyethanol, gelatin, polyvinylpyrrolidone, vinylpyrrolidone vinylacetate copolymer or polyoxyethylsorbitan monooleate or mixtures thereof
- 6. Method of claim 5, wherein said hexadecylphosphocholine is administered in the form of a tablet or capsule.
- 7. Method of claim 5, wherein said hexadecylphosphocholine is administered in dose ranging from 5 mg to 2000 mg.
- 8. Method of claim 1, wherein said hexadecylphosphocholine is administered in connection with a non-ionic emulsifier or an ionic emulsifier.
- 9. The method of claim 1, wherein said hexadecylphosphocholine is administered in the form of a mixture consisting essentially of 5 to 200 mg of hexadecylphosphocholine and a pharmaceutically acceptable carrier.
- 10. Method of claim 9 wherein said mixture contains water.
- 11. Method of claim 9, wherein said mixture is administered in the form of a composition suitable for local application.
- 12. Method of claim 11, wherein said mixture is administered two or three times per day.
- 13. Method of claim 11, wherein said mixture is administered to a skin tumor or skin metastasis.
- 14. Method of claim 13, wherein said skin metastasis is a mammary carcinoma.
- 15. Method of claim 9, wherein said mixture is administered in the form of a solution, a suppository, an oral medicament, a parenteral medicament or a medicament suitable for local administration.
- 16. Method of claim 15, wherein said hexadecylphosphocholine is administered in a parenteral medicament which further comprises a physiologically acceptable salt solution in an amount ranging from 5 to 100 mg of hexadecylphosphocholine per kilogram of body weight of said patient.
- 17. Method of claim 15, wherein said hexadecylphosphocholine is administered in a medicament suitable for local administration which contains from 50 mg to 2000 mg of hexadecylphosphocholine.
Priority Claims (2)
Number |
Date |
Country |
Kind |
3542893 |
Dec 1985 |
DEX |
|
3606631 |
Feb 1986 |
DEX |
|
Parent Case Info
This application is a divisional of Ser. No. 097,960, filed as PCT/EP86/00705 on Dec. 4, 1986, published as WO87/03480 on June 18, 1987 now U.S. Pat. No. 4,837,023.
Non-Patent Literature Citations (4)
Entry |
Chemical Abstracts 101:23066g (1984). |
Chemical Abstracts 108:48864k (1988). |
Chemical Abstracts 108:87670p (1988). |
Chemical Abstracts 108:179609d (1988). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
97960 |
Oct 1987 |
|